The FINANCIAL — A Merseyside man has become the first in the UK to receive a ‘vaccine’ that is hoped will stop his recurring head and neck cancer from returning – in a clinical research trial which may help bring further ground-breaking treatments for the disease.…
Read More »
The FINANCIAL — A Merseyside man has become the first in the UK to receive a ‘vaccine’ that is hoped will stop his recurring head and neck cancer from returning – in a clinical research trial which may help bring further ground-breaking treatments for the disease.…
You might be interested in
It’s like we forgot how to drive, one Harvard expert observed recently about the two-year spike in traffic-related deaths, which…
SARS-CoV-2 infection can trigger the production of immune molecules that damage cells lining blood vessels in the brain, causing platelets…
The FINANCIAL — Researchers have found that around one in 500 men could be carrying an extra X or Y…
The FINANCIAL — COVID-19 was the third leading cause of death in the United States between March 2020 and October…